Amphetamines take two to tango: An oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action

Molecular Pharmacology

Volumn 67, Issue 1, 2005, Pages 140-151

  Seidel, Stefan ^a   Singer, Ernst A ^a   Just, Herwig ^a   Farhan, Hesso ^a   Scholze, Petra ^a   Kudlacek, Oliver ^a   Holy, Marion ^a   Koppatz, Karl ^a   Krivanek, Peter ^a   Freissmuth, Michael ^a   Sitte, Harald H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; 4 AMINOBUTYRIC ACID; AMPHETAMINE; DOPAMINE TRANSPORTER; MONOAMINE; NORADRENALIN TRANSPORTER; OLIGOMER; PROTEIN KINASE C; SEROTONIN TRANSPORTER; TRANSCRIPTION FACTOR GATA 1;

4 AMINOBUTYRIC ACID UPTAKE; ARTICLE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; NEUROTRANSMISSION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN CONFORMATION;

EID: 19944429021     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.67.1.140     Document Type: Article

References (40)

1. Abramson J, Smirnova I, Kasho V, Verner G, Kaback HR, and Iwata S (2003) Structure and mechanism of the lactose permease of Escherichia coli. Science (Wash DC) 301:610-615.
2. Adams SV and DeFelice LJ (2003) Ionic currents in the human serotonin transporter reveal inconsistencies in the alternating access hypothesis. Biophys J 85:1548-1559.
3. 3H-norepinephrine by tissues. Science (Wash DC) 133:383-384.
4. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, and Poulton R (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (Wash DC) 301:386-389.
5. Chen NH, Reith ME, and Quick MW (2004) Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflueg Arch Eur J Physiol 447:519-531.
6. Farhan H, Korkhov VM, Paulitschke V, Dorostkar MM, Scholze P, Kudalcek O, Freissmuth M, and Sitte HH (2004) Two discontinuous segments in the carboxy terminus are required for membrane targeting of the rat GABA transporter-1 (GAT1). J Biol Chem 279:28553-28563.
7. Fischer JF and Cho AK (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208:203-209.
8. Giambalvo CT (1992a) Protein kinase C and dopamine transport. 1. Effects of amphetamine in vivo. Neuropharmacology 31:1201-1210.
9. Giambalvo CT (1992b) Protein kinase C and dopamine transport. 2. Effects of amphetamine in vitro. Neuropharmacology 31:1211-1222.
10. Giambalvo CT (2003) Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes. Synapse 49:125-133.
11. Gobbi M, Moia M, Pirona L, Ceglia I, Reyes-Parada M, Scorza C, and Mennini T (2002) p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro. J Neurochem 82:1435-1443.
12. Hahn MK, Robertson D, and Blakely RD (2003) A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. J Neurosci 23:4470-4478.
13. Hastrup H, Karlin A, and Javitch JA (2001) Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment. Proc Natl Acad Sci USA 98:10055-10060.
14. Hastrup H, Sen N, and Javitch JA (2003) The human dopamine transporter forms a tetramer in the plasma membrane: cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs. J Biol Chem 278:45045-45048.
15. Henderson PJ (1993) The 12-transmembrane helix transporters. Curr Opin Cell Biol 5:708-721.
16. Horschitz S, Hummerich R, and Schloss P (2003) Functional coupling of serotonin and noradrenaline transporters. J Neurochem 86:958-965.
17. Huang Y, Lemieux MJ, Song J, Auer M, and Wang DN (2003) Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science (Wash DC) 301:616-620.
18. Kramer HK, Poblete JC, and Azmitia EC (1998) Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/Ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT). Neuropsychopharmacology 19:265-277.
19. Jardetzky O (1966) Simple allosteric model for membrane pumps. Nature (Lond) 211:969-970.
20. Just H, Sitte HH, Schmid JA, Freissmuth M, and Kudlacek O (2004) Identification of an additional interaction domain in transmembrane domains 11 and 12 that supports oligomer formation in the human serotonin transporter. J Biol Chem 279:6650-6657.
21. Kantor L and Gnegy ME (1998) Protein kinase c inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J Pharmacol Exp Ther 284:592-598.
22. Khoshbouei H, Sen N, Guptaroy B, Johnson L, Lund D, Gnegy ME, Galli A, and Javitch JA (2004) N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol 2:E78.
23. +-dependent mechanism. J Biol Chem 278:12070-12077.
24. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, and Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (Wash DC) 274:1527-1531.
25. 3H-noradrenaline releasing effect of various substrates of uptake1: multifactorial induction of outward transport. Naunyn- Schmiedeberg's Arch Pharmacol 336:602-610.
26. Pifl C and Singer EA (1999) Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of facilitated exchange diffusion. Mol Pharmacol 56:1047-1054.
27. Ramamoorthy S and Blakely RD (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science (Wash DC) 285:763-766.
28. Rudnick G (1998) Bioenergetics of neurotransmitter transport. J Bioenerg Biomembr 30:173-185.
29. Schmid JA, Scholze P, Kudlacek O, Freissmuth M, Singer EA, and Sitte HH (2001) Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells. J Biol Chem 276:3805-3810.
30. Scholze P, Sitte HH, and Singer EA (2001) Substantial loss of substrate by diffusion during uptake in HEK-293 cells expressing neurotransmitter transporters. Neurosci Lett. 309:173-176.
31. Scholze P, Freissmuth M, and Sitte HH (2002) Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1. J Biol Chem 277:43682-43690.
32. Schwartz JW, Blakely RD, and DeFelice LJ (2003) Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate. J Biol Chem 278:9768-9777.
33. Shannon JR, Flattern NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, and Robertson D (2000) Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 342:541-549.
34. --coupled neurotransmitter transporters. Eur J Pharmacol 479:229-236.
35. Sitte HH, Hiptmair B, Zwach J, Pifl C, Singer EA, and Scholze P (2001) Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion. Mol Pharmacol 59:1129-1137.
36. Sitte HH, Huck S, Reither H, Boehm S, Singer EA, and Pifl C (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71:1289-1297.
37. Sorkina T, Doolen S, Galperin E, Zahniser NR, and Sorkin A (2003) Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy. J Biol Chem 278:28274-28283.
38. Torres GE, Carneiro A, Seamans K, Fiorentini C, Sweeney A, Yao WD, and Caron MG (2003a) Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem 278:2731-2739.
39. Torres GE, Gainetdinov RR, and Caron MG (2003b) Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4:13-25.
40. Whitworth TL, Herndon LC, and Quick MW (2002) Psychostimulants differentially regulate serotonin transporter expression in thalamocortical neurons. J Neurosci 22:RC192.